Published in Front Physiol on June 04, 2013
Further steps toward functional systems biology of cancer. Front Physiol (2013) 0.84
How interacting pathways are regulated by miRNAs in breast cancer subtypes. BMC Bioinformatics (2016) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The hallmarks of cancer. Cell (2000) 113.05
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02
KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (2012) 20.47
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2005) 19.56
Wnt signalling in stem cells and cancer. Nature (2005) 19.26
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature (2010) 18.69
Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31
TGFbeta in Cancer. Cell (2008) 17.44
Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res (2008) 15.69
STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer (2009) 15.45
Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res (2003) 14.79
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature (2010) 14.62
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst (2006) 14.60
Concordance among gene-expression-based predictors for breast cancer. N Engl J Med (2006) 13.50
Cell signaling by receptor tyrosine kinases. Cell (2010) 12.39
Network-based classification of breast cancer metastasis. Mol Syst Biol (2007) 12.18
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
The DNA damage response: ten years after. Mol Cell (2007) 11.80
Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res (2010) 11.23
Signalling downstream of activated mammalian Notch. Nature (1995) 11.08
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature (2007) 10.98
Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell (2009) 10.50
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A (2004) 9.42
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer (2010) 8.55
The highways and byways of mRNA decay. Nat Rev Mol Cell Biol (2007) 8.42
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell (1992) 8.20
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res (2008) 8.17
Outcome signature genes in breast cancer: is there a unique set? Bioinformatics (2004) 7.96
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell (2003) 7.93
The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther (2004) 7.82
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Receptor specificity of the fibroblast growth factor family. J Biol Chem (1996) 7.58
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A (2006) 6.80
Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol (2009) 6.66
The many ways of Wnt in cancer. Curr Opin Genet Dev (2007) 6.29
Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature (2002) 6.26
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev (2006) 6.19
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem (2006) 5.78
Guilty as charged: B-RAF is a human oncogene. Cancer Cell (2004) 4.97
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene (2007) 4.80
The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer (2012) 4.72
Notch signaling: the core pathway and its posttranslational regulation. Dev Cell (2009) 4.49
c-Src and cooperating partners in human cancer. Cancer Cell (2004) 4.22
Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer (2011) 4.12
The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol (2009) 3.85
Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol (2011) 3.81
DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene (2007) 3.67
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev (2009) 3.53
ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res (2006) 3.33
Crk family adaptors-signalling complex formation and biological roles. Oncogene (2001) 3.11
Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc Natl Acad Sci U S A (2006) 2.92
Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol (2006) 2.85
Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet (1999) 2.84
The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer (2012) 2.79
Judging the quality of gene expression-based clustering methods using gene annotation. Genome Res (2002) 2.76
Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell (2002) 2.67
Fibroblast growth factors and their receptors in cancer. Biochem J (2011) 2.66
PDGF signaling in cells and mice. Cytokine Growth Factor Rev (2004) 2.57
Signaling via Shc family adapter proteins. Oncogene (2001) 2.51
Predicting features of breast cancer with gene expression patterns. Breast Cancer Res Treat (2007) 2.49
Retracted The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol (2006) 2.42
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res (2008) 2.37
CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature (2006) 2.35
Paracrine Hedgehog signaling in cancer. Cancer Res (2009) 2.21
Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability. BMC Genomics (2005) 2.18
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell (2009) 2.13
Mutations of the human PTEN gene. Hum Mutat (2000) 2.11
A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J Biol Chem (1994) 1.87
Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am J Pathol (2009) 1.81
Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J (2004) 1.79
Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci (2008) 1.77
Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene (2007) 1.76
Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett (2001) 1.64
Paths of FGFR-driven tumorigenesis. Cell Cycle (2009) 1.63
Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim Biophys Acta (1995) 1.61
Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene (2001) 1.57
A prognostic gene expression index in ovarian cancer - validation across different independent data sets. J Pathol (2009) 1.55
Roles for growth factors in cancer progression. Physiology (Bethesda) (2010) 1.48
Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res (2005) 1.47
Aberrant regulation of messenger RNA 3'-untranslated region in human cancer. Cell Oncol (2007) 1.44
Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC). PLoS Comput Biol (2010) 1.38
SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction. Genes Cells (1996) 1.34
Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Biochem J (2007) 1.27
The contribution of RNA decay quantitative trait loci to inter-individual variation in steady-state gene expression levels. PLoS Genet (2012) 1.25
Identification of coordinately dysregulated subnetworks in complex phenotypes. Pac Symp Biocomput (2010) 1.22
mRNA stability and cancer: an emerging link? Expert Opin Biol Ther (2007) 1.18
Inferring cancer subnetwork markers using density-constrained biclustering. Bioinformatics (2010) 1.13
Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin. Cancer Res (2004) 1.13
Cell cycle markers in clinical oncology. Curr Opin Cell Biol (2007) 1.12
Cell signalling: growth factors and tyrosine kinase receptors. Clin Transl Oncol (2006) 1.09
ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res (2010) 2.79
ConsensusPathDB--a database for integrating human functional interaction networks. Nucleic Acids Res (2008) 2.77
Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells (2005) 1.68
Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. EMBO Mol Med (2012) 1.27
GeNGe: systematic generation of gene regulatory networks. Bioinformatics (2009) 1.11
High-throughput miRNA and mRNA sequencing of paired colorectal normal, tumor and metastasis tissues and bioinformatic modeling of miRNA-1 therapeutic applications. PLoS One (2013) 1.00
The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors. Mol Cancer (2011) 0.87
Prediction in the face of uncertainty: a Monte Carlo-based approach for systems biology of cancer treatment. Mutat Res (2012) 0.85
A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells. Front Physiol (2012) 0.82
Inferring dynamic properties of biochemical reaction networks from structural knowledge. Genome Inform (2004) 0.82
Modeling of miRNA and drug action in the EGFR signaling pathway. PLoS One (2012) 0.81
Monte Carlo analysis of an ODE Model of the Sea Urchin Endomesoderm Network. BMC Syst Biol (2009) 0.79
PROTEOMER: A workflow-optimized laboratory information management system for 2-D electrophoresis-centered proteomics. Proteomics (2009) 0.76
Standards, tools, and databases for the analysis of yeast 'omics data. Methods Mol Biol (2011) 0.75